Delaware | 001-40208 | 82-2060643 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common stock, par value $0.001 per share | HAYW | New York Stock Exchange |
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits |
Exhibit No. | Description | |||||||
Press Release of the Company, dated February 27, 2025 |
||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
HAYWARD HOLDINGS, INC. | ||||||||
Date: February 27, 2025 |
By: | /s/ Eifion Jones | ||||||
Eifion Jones | ||||||||
Senior Vice President and Chief Financial Officer |
December 31, 2024 | December 31, 2023 | |||||||||||||
Assets | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents | $ | 196,589 | $ | 178,097 | ||||||||||
Short-term investments |
— | 25,000 | ||||||||||||
Accounts receivable, net of allowances of $2,701 and $2,870, respectively |
278,582 | 270,875 | ||||||||||||
Inventories, net | 216,472 | 215,180 | ||||||||||||
Prepaid expenses | 20,203 | 14,331 | ||||||||||||
Income tax receivable | 6,426 | 9,994 | ||||||||||||
Other current assets | 48,697 | 11,264 | ||||||||||||
Total current assets | 766,969 | 724,741 | ||||||||||||
Property, plant, and equipment, net of accumulated depreciation of $112,099 and $95,917, respectively |
160,377 | 158,979 | ||||||||||||
Goodwill | 943,645 | 935,013 | ||||||||||||
Trademark | 736,000 | 736,000 | ||||||||||||
Customer relationships, net | 198,333 | 206,308 | ||||||||||||
Other intangibles, net | 96,095 | 94,082 | ||||||||||||
Other non-current assets | 89,205 | 91,161 | ||||||||||||
Total assets | $ | 2,990,624 | $ | 2,946,284 | ||||||||||
Liabilities and Stockholders’ Equity |
||||||||||||||
Current liabilities | ||||||||||||||
Current portion of long-term debt | $ | 13,991 | $ | 15,088 | ||||||||||
Accounts payable | 81,476 | 68,943 | ||||||||||||
Accrued expenses and other liabilities | 217,242 | 155,543 | ||||||||||||
Income taxes payable | 273 | 109 | ||||||||||||
Total current liabilities | 312,982 | 239,683 | ||||||||||||
Long-term debt, net | 950,562 | 1,079,280 | ||||||||||||
Deferred tax liabilities, net | 239,111 | 248,967 | ||||||||||||
Other non-current liabilities | 64,322 | 66,896 | ||||||||||||
Total liabilities | 1,566,977 | 1,634,826 | ||||||||||||
Stockholders’ equity |
||||||||||||||
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of December 31, 2024 and December 31, 2023 |
— | — | ||||||||||||
Common stock $0.001 par value, 750,000,000 authorized; 244,444,889 issued and 215,778,520 outstanding at December 31, 2024; 242,832,045 issued and 214,165,676 outstanding at December 31, 2023 |
245 | 243 | ||||||||||||
Additional paid-in capital | 1,093,468 | 1,080,894 | ||||||||||||
Common stock in treasury; 28,666,369 and 28,666,369 at December 31, 2024 and December 31, 2023, respectively |
(358,133) | (357,755) | ||||||||||||
Retained earnings | 699,564 | 580,909 | ||||||||||||
Accumulated other comprehensive income (loss) | (11,497) | 7,167 | ||||||||||||
Total stockholders’ equity |
1,423,647 | 1,311,458 | ||||||||||||
Total liabilities, redeemable stock, and stockholders’ equity |
$ | 2,990,624 | $ | 2,946,284 |
Three Months Ended | Twelve Months Ended | |||||||||||||||||||||||||
December 31, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||
Net sales | $ | 327,075 | $ | 278,469 | $ | 1,051,606 | $ | 992,452 | ||||||||||||||||||
Cost of sales | 159,079 | 141,331 | 520,849 | 515,502 | ||||||||||||||||||||||
Gross profit | 167,996 | 137,138 | 530,757 | 476,950 | ||||||||||||||||||||||
Selling, general and administrative expense | 73,250 | 61,550 | 260,928 | 233,607 | ||||||||||||||||||||||
Research, development and engineering expense | 6,908 | 5,520 | 25,778 | 24,547 | ||||||||||||||||||||||
Acquisition and restructuring related expense | 3,976 | 6,993 | 6,464 | 13,213 | ||||||||||||||||||||||
Amortization of intangible assets | 7,375 | 7,584 | 28,800 | 30,361 | ||||||||||||||||||||||
Operating income | 76,487 | 55,491 | 208,787 | 175,222 | ||||||||||||||||||||||
Interest expense, net | 13,563 | 17,645 | 62,163 | 73,584 | ||||||||||||||||||||||
Loss on debt extinguishment | — | — | 4,926 | — | ||||||||||||||||||||||
Other (income) expense, net | (495) | (1,247) | (2,484) | 551 | ||||||||||||||||||||||
Total other expense | 13,068 | 16,398 | 64,605 | 74,135 | ||||||||||||||||||||||
Income from operations before income taxes | 63,419 | 39,093 | 144,182 | 101,087 | ||||||||||||||||||||||
Provision for income taxes | 8,686 | 8,057 | 25,527 | 20,400 | ||||||||||||||||||||||
Net income | $ | 54,733 | $ | 31,036 | $ | 118,655 | $ | 80,687 | ||||||||||||||||||
Earnings per share | ||||||||||||||||||||||||||
Basic | $ | 0.25 | $ | 0.15 | $ | 0.55 | $ | 0.38 | ||||||||||||||||||
Diluted | $ | 0.25 | $ | 0.14 | $ | 0.54 | $ | 0.37 | ||||||||||||||||||
Weighted average common shares outstanding | ||||||||||||||||||||||||||
Basic | 215,584,373 | 213,768,108 | 215,028,683 | 213,144,063 | ||||||||||||||||||||||
Diluted | 221,872,482 | 220,848,098 | 221,370,188 | 220,688,616 |
Hayward Holdings, Inc.
Unaudited Consolidated Statements of Cash Flows
(In thousands)
|
Year Ended | |||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net income | $ | 118,655 | $ | 80,687 | ||||||||||
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||||||||
Depreciation | 20,078 | 15,983 | ||||||||||||
Amortization of intangible assets | 35,783 | 37,079 | ||||||||||||
Amortization of deferred debt issuance fees | 4,203 | 4,696 | ||||||||||||
Stock-based compensation | 10,595 | 9,165 | ||||||||||||
Deferred income taxes | (10,514) | (12,786) | ||||||||||||
Allowance for bad debts | (169) | (1,067) | ||||||||||||
Loss on debt extinguishment | 4,926 | — | ||||||||||||
Loss on impairment | — | 6,720 | ||||||||||||
(Gain) loss on sale of property, plant and equipment | (428) | 1,000 | ||||||||||||
Changes in operating assets and liabilities | ||||||||||||||
Accounts receivable | (7,260) | (58,700) | ||||||||||||
Inventories | 4,330 | 67,824 | ||||||||||||
Other current and non-current assets | (41,167) | 24,820 | ||||||||||||
Accounts payable | 11,794 | 14,551 | ||||||||||||
Accrued expenses and other liabilities | 61,242 | (5,432) | ||||||||||||
Net cash provided by operating activities | 212,068 | 184,540 | ||||||||||||
Cash flows from investing activities | ||||||||||||||
Purchases of property, plant, and equipment | (24,289) | (30,994) | ||||||||||||
Purchases of short-term investments |
— | (25,000) | ||||||||||||
Acquisitions, net of cash acquired | (55,153) | — | ||||||||||||
Proceeds from sale of property, plant, and equipment | 311 | 613 | ||||||||||||
Proceeds from short-term investments | 25,000 | — | ||||||||||||
Net cash used in investing activities | (54,131) | (55,381) | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Purchases of common stock for treasury | (378) | — | ||||||||||||
Proceeds from issuance of long-term debt | 2,886 | 5,448 | ||||||||||||
Payments of long-term debt | (138,638) | (12,518) | ||||||||||||
Proceeds from revolving credit facility | — | 144,100 | ||||||||||||
Payments on revolving credit facility | — | (144,100) | ||||||||||||
Proceeds from issuance of short term debt | 6,340 | 6,130 | ||||||||||||
Payments of short term debt | (6,463) | (6,894) | ||||||||||||
Other, net | (537) | 222 | ||||||||||||
Net cash used in financing activities | (136,790) | (7,612) | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
(2,655) | 373 | ||||||||||||
Change in cash and cash equivalents |
18,492 | 121,920 | ||||||||||||
Cash and cash equivalents, beginning of year |
178,097 | 56,177 | ||||||||||||
Cash and cash equivalents, end of year |
$ | 196,589 | $ | 178,097 | ||||||||||
Supplemental disclosures of cash flow information: | ||||||||||||||
Cash paid-interest | $ | 68,476 | $ | 75,658 | ||||||||||
Cash paid-income taxes | 35,938 | 16,420 | ||||||||||||
Non-cash investing and financing activities: |
||||||||||||||
Accrued and unpaid purchases of property, plant, and equipment |
$ | 4,567 | $ | 1,150 | ||||||||||
Equipment financed under finance leases | 1,046 | (21) |
(Dollars in thousands) | Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||||
December 31, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||
Net income | $ | 54,733 | $ | 31,036 | $ | 118,655 | $ | 80,687 | ||||||||||||||||||
Depreciation | 6,149 | 2,965 | 20,078 | 15,983 | ||||||||||||||||||||||
Amortization | 9,484 | 9,276 | 35,783 | 37,079 | ||||||||||||||||||||||
Interest expense | 13,563 | 17,645 | 62,163 | 73,584 | ||||||||||||||||||||||
Income taxes | 8,686 | 8,057 | 25,527 | 20,400 | ||||||||||||||||||||||
Loss on extinguishment of debt | — | — | 4,926 | — | ||||||||||||||||||||||
EBITDA | 92,615 | 68,979 | 267,132 | 227,733 | ||||||||||||||||||||||
Stock-based compensation(a) |
52 | 269 | 608 | 1,270 | ||||||||||||||||||||||
Currency exchange items(b) |
(366) | (490) | (836) | 786 | ||||||||||||||||||||||
Acquisition and restructuring related expense, net(c) |
3,976 | 6,993 | 6,464 | 13,213 | ||||||||||||||||||||||
Other(d) |
2,422 | (96) | 4,079 | 4,271 | ||||||||||||||||||||||
Total Adjustments | 6,084 | 6,676 | 10,315 | 19,540 | ||||||||||||||||||||||
Adjusted EBITDA | $ | 98,699 | $ | 75,655 | $ | 277,447 | $ | 247,273 | ||||||||||||||||||
Net income margin | 16.7 | % | 11.1 | % | 11.3 | % | 8.1 | % | ||||||||||||||||||
Adjusted EBITDA margin | 30.2 | % | 27.2 | % | 26.4 | % | 24.9 | % |
(a) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s initial public offering (the “IPO”). | |||||||
(b) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
(c) |
Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Also included in adjustments for the fiscal quarter ended December 31, 2024 is $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business.
Adjustments in the fiscal quarter ended December 31, 2023 are primarily driven by $6.7 million of costs related to the discontinuation of a product line leading to an impairment of the associated fixed assets, inventory and intangible assets.
|
|||||||
Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. Adjustments in the year ended December 31, 2023 primarily include $6.7 million of costs related to the discontinuation of a product line leading to an impairment of the associated fixed assets, inventory and intangible assets, $2.4 million related to programs to centralize and consolidate manufacturing operations and professional services in Europe, $1.9 million of costs associated with the relocation of the corporate headquarters to Charlotte, North Carolina, $1.2 million separation costs associated with the 2022 cost reduction program and $0.8 million of costs associated with integration costs from prior acquisitions. |
||||||||
(d) |
Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility.
Adjustments in the fiscal quarter ended December 31, 2023 are primarily related to programs to centralize and consolidate operations and professional services in Europe.
|
|||||||
Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. Adjustments in the year ended December 31, 2023 primarily include $1.8 million related to inventory and fixed asset write-offs in Europe and $1.5 million of costs incurred related to the selling stockholder offerings of shares in March, May and August 2023, which are reported in SG&A in our consolidated statements of operations. |
(Dollars in thousands, except per share data) | Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||||
December 31, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||
Net income | $ | 54,733 | $ | 31,036 | $ | 118,655 | $ | 80,687 | ||||||||||||||||||
Tax adjustments (a) |
(7,167) | 974 | (9,389) | (1,930) | ||||||||||||||||||||||
Other adjustments and amortization: | ||||||||||||||||||||||||||
Stock-based compensation (b) |
52 | 269 | 608 | 1,270 | ||||||||||||||||||||||
Currency exchange items (c) |
(366) | (490) | (836) | 786 | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (d) |
3,976 | 6,993 | 6,464 | 13,213 | ||||||||||||||||||||||
Other (e) |
2,422 | (96) | 4,079 | 4,271 | ||||||||||||||||||||||
Total other adjustments | 6,084 | 6,676 | 10,315 | 19,540 | ||||||||||||||||||||||
Loss on extinguishment of debt | — | — | 4,926 | — | ||||||||||||||||||||||
Amortization | 9,484 | 9,276 | 35,783 | 37,079 | ||||||||||||||||||||||
Tax effect (f) |
(3,892) | (2,890) | (12,356) | (12,507) | ||||||||||||||||||||||
Adjusted net income | $ | 59,242 | $ | 45,072 | $ | 147,934 | $ | 122,869 | ||||||||||||||||||
Weighted average number of common shares outstanding, basic | 215,584,373 | 213,768,108 | 215,028,683 | 213,144,063 | ||||||||||||||||||||||
Weighted average number of common shares outstanding, diluted | 221,872,482 | 220,848,098 | 221,370,188 | 220,688,616 | ||||||||||||||||||||||
Basic EPS | $ | 0.25 | $ | 0.15 | $ | 0.55 | $ | 0.38 | ||||||||||||||||||
Diluted EPS | $ | 0.25 | $ | 0.14 | $ | 0.54 | $ | 0.37 | ||||||||||||||||||
Adjusted basic EPS | $ | 0.27 | $ | 0.21 | 0.69 | 0.58 | ||||||||||||||||||||
Adjusted diluted EPS | $ | 0.27 | $ | 0.20 | 0.67 | 0.56 |
(a) | Tax adjustments for the three and twelve months ended December 31, 2024 reflect a normalized tax rate of 25% and 24.2% compared to our effective tax rate of 13.7% and 17.7%, respectively. Our effective tax rate for the three and twelve months ended December 31, 2024 primarily includes the tax benefits resulting from prior period return-to-provision adjustments, revaluation of deferred tax liabilities as a result of state tax changes, and the exercise of stock options along with other miscellaneous items. Tax adjustments for the three and twelve months ended December 31, 2023 reflect a normalized tax rate of 18.1% and 22.1% compared to our effective tax rate of 20.6% and 20.2%, respectively. Our effective tax rate for the three months ended December 31, 2023 includes discrete tax expenses related to state tax audit settlements and stock options exercises, partially offset by the tax benefits from a state franchise tax adjustment and other miscellaneous items. Our effective tax rate for the twelve months ended December 31, 2023 includes the tax benefits resulting from the exercise of stock options and prior period return-to-provision adjustments, partially offset by the impact of a discrete tax expense related to a change in the indefinite reinvestment assertion for one jurisdiction and other miscellaneous items. |
|||||||
(b) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s IPO. | |||||||
(c) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
(d) |
Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Also included in adjustments for the fiscal quarter ended December 31, 2024 is $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business.
Adjustments in the fiscal quarter ended December 31, 2023 are primarily driven by $6.7 million of costs related to the discontinuation of a product line leading to an impairment of the associated fixed assets, inventory and intangible assets.
|
|||||||
Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. Adjustments in the year ended December 31, 2023 primarily include $6.7 million of costs related to the discontinuation of a product line leading to an impairment of the associated fixed assets, inventory and intangible assets, $2.4 million related to programs to centralize and consolidate manufacturing operations and professional services in Europe, $1.9 million of costs associated with the relocation of the corporate headquarters to Charlotte, North Carolina, $1.2 million separation costs associated with the 2022 cost reduction program and $0.8 million of costs associated with integration costs from prior acquisitions. |
||||||||
(e) |
Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility.
Adjustments in the fiscal quarter ended December 31, 2023 are primarily related to programs to centralize and consolidate operations and professional services in Europe.
|
|||||||
Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. Adjustments in the year ended December 31, 2023 primarily include $1.8 million related to inventory and fixed asset write-offs in Europe and $1.5 million of costs incurred related to the selling stockholder offerings of shares in March, May and August 2023, which are reported in SG&A in our consolidated statements of operations. |
||||||||
(f) | The tax effect represents the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above. | |||||||
(Dollars in thousands) | Three Months Ended | Three Months Ended | ||||||||||||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
Segment income | $ | 95,089 | $ | 4,832 | $ | 71,079 | $ | 7,871 | ||||||||||||||||||
Depreciation | $ | 5,370 | $ | 424 | $ | 2,658 | $ | 246 | ||||||||||||||||||
Amortization | 2,111 | — | 1,692 | — | ||||||||||||||||||||||
Stock-based compensation | — | — | 20 | 11 | ||||||||||||||||||||||
Other (a) |
2,356 | — | — | — | ||||||||||||||||||||||
Total adjustments | 9,837 | 424 | 4,370 | 257 | ||||||||||||||||||||||
Adjusted segment income | $ | 104,926 | $ | 5,256 | $ | 75,449 | $ | 8,128 | ||||||||||||||||||
Segment income margin % | 33.2 | % | 11.8 | % | 29.8 | % | 19.5 | % | ||||||||||||||||||
Adjusted segment income margin % | 36.7 | % | 12.8 | % | 31.7 | % | 20.2 | % |
(a) | Adjustments in the fiscal quarter ended December 31, 2024 for NAM are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. |
|||||||
(Dollars in thousands) | Twelve Months Ended | Twelve Months Ended | ||||||||||||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
Segment income | $ | 261,735 | $ | 21,632 | $ | 215,425 | $ | 33,518 | ||||||||||||||||||
Depreciation | $ | 17,989 | $ | 1,215 | $ | 14,610 | $ | 940 | ||||||||||||||||||
Amortization | 6,985 | — | 6,718 | — | ||||||||||||||||||||||
Stock-based compensation | 176 | 10 | 437 | 45 | ||||||||||||||||||||||
Other (a) |
4,079 | — | 503 | — | ||||||||||||||||||||||
Total adjustments | 29,229 | 1,225 | 22,268 | 985 | ||||||||||||||||||||||
Adjusted segment income |
$ | 290,964 | $ | 22,857 | $ | 237,693 | $ | 34,503 | ||||||||||||||||||
Segment income margin % | 29.2 | % | 13.9 | % | 26.2 | % | 19.8 | % | ||||||||||||||||||
Adjusted segment income margin % |
32.5 | % | 14.6 | % | 28.9 | % | 20.4 | % |
(a) |
Adjustments in the year ended December 31, 2024 for NAM include a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs related to a flood sustained at a contract manufacturer. Adjustments in the year ended December 31, 2023 for NAM include miscellaneous items we believe are not representative of our ongoing business operations. |
|||||||